Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Appoints Arthur Collins chief operating officer with responsibility for operations "both inside and outside the United States." Collins, previously exec VP and president of Medtronic International, came to Medtronic in June 1992 from Abbott Laboratories, where he headed its diagnostic business units. Collins fills the position that was left vacant by William George, who became president and chief executive officer of the company in May 1991
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.